At a journal club sponsored by the George Wash-ington University Department of
Ophthalmology in March 2003, we read and discussed with great interest the case series by …

Background: Diabetic macular edema causes visual loss in almost one-third of diabetic
patients. There is currently no treatment for the accompanying cystoid foveal changes …

OBJECTIVE: To report the results of repeated intravitreal injections of triamcinolone
acetonide for treatment of diffuse diabetic macular edema. DESIGN: Retrospective …

Objective To evaluate the clinical outcome of an intravitreal injection of triamcinolone
acetonide as treatment of diffuse diabetic macular edema. Participants This prospective …

Purpose: To evaluate prospectively the efficacy and safety of one intravitreal injection of 4mg
triamcinolone acetonide for refractory diffuse diabetic macular edema. Methods: Seventeen …

Purpose To report on the follow-up of patients who received an intravitreal high-dosage
injection of triamcinolone acetonide (IVTA) as treatment of diffuse diabetic macular edema …

Purpose To evaluate the clinical and volumetric improvement 1 week after an injection of
intravitreal triamcinolone acetonide in eyes with diabetic macular oedema. Methods Seven …

Aim: To evaluate the predictive factors for visual outcome after intravitreal triamcinolone
acetonide injection to treat refractory diabetic macular oedema (DME). Methods: A …

Purpose To evaluate the effectiveness of intravitreal triamcinolone injection on the course of
diabetic macular edema. Methods Forty-eight eyes of 48 diabetic patients were treated with …

The aim of the present prospective controlled trial was to evaluate the adjuvant role of
posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema …